The estimated Net Worth of Corp Plc Elan Science Three... is at least $587 Million dollars as of 13 March 2012. Corp Three owns over 24,150,000 units of Alkermes plc stock worth over $205,917,500 and over the last 13 years Corp sold ALKS stock worth over $381,570,000.
Corp has made over 1 trades of the Alkermes plc stock since 2012, according to the Form 4 filled with the SEC. Most recently Corp sold 24,150,000 units of ALKS stock worth $381,570,000 on 13 March 2012.
The largest trade Corp's ever made was selling 24,150,000 units of Alkermes plc stock on 13 March 2012 worth over $381,570,000. On average, Corp trades about 24,150,000 units every 0 days since 2012. As of 13 March 2012 Corp still owns at least 7,750,000 units of Alkermes plc stock.
You can see the complete history of Corp Three stock trades at the bottom of the page.
Over the last 13 years, insiders at Alkermes plc have traded over $407,046,771 worth of Alkermes plc stock and bought 86,119 units worth $2,034,840 . The most active insiders traders include Corp Plc Elan Science Three..., Richard F Pops, and James M Frates. On average, Alkermes plc executives and independent directors trade stock every 5 days with the average trade being worth of $1,083,232. The most recent stock trade was executed by David Joseph Gaffin on 3 August 2024, trading 2,014 units of ALKS stock currently worth $53,512.
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Alkermes plc executives and other stock owners filed with the SEC include: